Organization
Adicet Bio
2 clinical trials
Clinical trial
A Phase 1 Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (γδ) T Cells in Adults With Lupus NephritisStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
A Phase 1 Safety and Efficacy Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma Delta (γδ) T Cells in Adults With B Cell MalignanciesStatus: Recruiting, Estimated PCD: 2025-12-31